SCHEMBL12213360

SCHEMBL12213360

C=C(C)C(=O)Oc1ccc(C(F)(F)Oc2ccc(OC(F)(F)c3ccc(OC(=O)C(=C)C)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.50
KMT2A Q03164 2/20 0.47
ATM Q13315 1/20 0.47
KIF11 P52732 1/20 0.38
TRPV1 Q8NER1 3/20 0.35
MAPT P10636 3/20 0.35
POLB P06746 2/20 0.35
PKM P14618 1/20 0.35
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
EPHX2 P34913 2/20 0.33
NR1H4 Q96RI1 1/20 0.33
MAOB P27338 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
APEX1 P27695 1/20 0.33
HTT P42858 1/20 0.33
PRSS1 P07477 1/20 0.32
ACR P10323 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15706220 1.00 ELANE (0.50) ELANEKMT2AATMKIF11TRPV1
SCHEMBL18118994 0.95 ELANE (0.47) ELANEKMT2AATMKIF11TRPV1
SCHEMBL16978246 0.95 ELANE (0.47) ELANEKMT2AATMKIF11TRPV1
SCHEMBL25695914 0.94 ELANE (0.46) ELANEKMT2AATMKIF11TRPV1
SCHEMBL25695936 0.94 ELANE (0.46) ELANEKMT2AATMKIF11TRPV1
SCHEMBL12214245 0.91 ELANE (0.46) ELANEKMT2AATMKIF11MAPT
SCHEMBL25695930 0.90 ELANE (0.43) ELANEKMT2AATMMAPTLMNA
SCHEMBL25695939 0.89 ELANE (0.48) ELANEKMT2AATMKIF11TRPV1
SCHEMBL25695910 0.87 ELANE (0.43) ELANEKMT2AATMKIF11MAPT
SCHEMBL12213832 0.86 ELANE (0.42) ELANEKMT2AATMKIF11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9347000-B2 Polymerisable compounds and the use thereof in liquid-crystal media and liquid-crystal displays MERCK PATENT GMBH (DE) 2016-05-24 US disclosed
US-20140362334-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL MEDIA AND LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2014-12-11 US disclosed
US-8895117-B2 Polymerisable compounds and the use thereof in liquid-crystal media and liquid-crystal displays MERCK PATENT GMBH (DE) 2014-11-25 US disclosed
US-20110261311-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL MEDIA AND LIQUID-CRYSTAL DISPLAYS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-10-27 US disclosed
EP-2380945-A1 Polymerisable compounds and use of same in liquid crystal media and liquid crystal displays Merck Patent GmbH (DE) 2011-10-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140362334-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL MEDIA AND LIQUID-CRYSTAL DISPLAYS LPXN, MAP1LC3C, VCL ELANE 1244/4885KMT2A 3647/4885ATM 944/4885
US-20110261311-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL MEDIA AND LIQUID-CRYSTAL DISPLAYS LPXN, MAP1LC3C, VCL ELANE 1244/4885KMT2A 3647/4885ATM 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.